Servier Group was founded by Jacques Servier in Orleans, France in 1954. A year later, the pharmaceutical company launched its first two treatments to help patients. Over the past 65 years, Servier Group has continued to expand through manufacturing, research and development, and partnerships across various global markets. Learn more about Servier’s history.
Servier opened its business presence in the United States in 2018 and made Boston’s Seaport District Servier Pharmaceuticals headquarters in 2019. Launched by Servier Group, a global organization governed by a non-profit foundation, Servier Pharmaceuticals strives to build a portfolio of innovative medicines that brings life-saving treatments to over 100 million patients around the world.
In the United States, Servier Pharmaceuticals aims to explore a broad spectrum of therapeutic innovation – from the earliest research stages through commercialization. Currently, Servier Pharmaceuticals has two oncology products on the market for acute lymphoblastic leukemia (ALL), with plans to expand into other therapeutic areas of unmet medical need.
More from Servier
Servier’s ambition to improve patient care comes from the top. Our best-in-class executives pave the way for success.Learn More
Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.Learn More
Servier Pharmaceuticals is a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.Learn More